Plans To Open 500 Pharma Stores Across Country
Bhubaneswar, Feb 19, 2026 : In a bid to make a mark and carve a niche in India’s digital healthcare service, “Tata 1mg” (touted to be India’s best online pharmacy as well as largest healthcare platform) has reportedly geared itself up to fly higher, while sky is the limit.
Even, Tata 1mg’s Initial Public Offering (IPO) in the stock market is likely after the fiscal year (FY) 2027 keeping in view the firm’s stupendous success story scripted and the graph of entire profit made by then. Now, its aim and objective is hitting the bull’s eye of being officially listed as a profitable company following which the shareholders could have a strong and sturdy say thenceforth.
Media reports have hinted at such a roadmap and blueprint of Tata 1mg’s state of affairs while quoting the company’s incumbent CEO Prashant Tandon.
Media reports, quoting the CEO, has also informed that Tata 1mg has already turned profitable in December last year (2025).
Media reports further state that the already popular brand name of every Indian household is now focused on a steady and sustainable growth as well as planning to open around 500 medicine stores across India by the end of the current year (2026).
By doing so, Tata 1mg seeks not only to retain its consumers’ base, but also to smoothly sell both the chronic and acute medicines on demand.
The CEO further explained that the Tate 1mg store in an area could enable and facilitate quick delivery in an economically profitable manner.
In a nutshell, Tata 1mg’s cherished business model is all poised to catering both the online and offline healthcare needs of Indian customers.
